Mylan N.V. (NASDAQ:MYL) has a beta value of 1.46 and has seen 2,965,283 shares traded in the recent trading session. The company, currently valued at $8.25 Billion, closed the recent trade at $15.83 per share which meant it lost -$0.12 on the day or -0.75% during that session. The MYL stock price is -45.99% off its 52-week high price of $23.11 and 19.46% above the 52-week low of $12.75. If we look at the company’s 10-day average daily trading volume, we find that it stood at 5.46 Million shares traded. The 3-month trading volume is 5.15 Million shares.
The consensus among analysts is that Mylan N.V. (MYL) is an Overweight stock at the moment, with a recommendation rating of 2.3. None of the analysts rate the stock as a Sell, while 2 rate it as Overweight. 7 out of 16 have rated it as a Hold, with 7 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $1.17.
Mylan N.V. (NASDAQ:MYL) trade information
Despite being -0.75% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Sep 15 when the MYL stock price touched $16.23- or saw a rise of 3.3%. Year-to-date, Mylan N.V. shares have moved -21.94%, while the 5-day performance has seen it change 2.89%. Over the past 30 days, the shares of Mylan N.V. (NASDAQ:MYL) have changed -3.09%. Short interest in the company has seen 44.1 Million shares shorted with days to cover at 8.56.
Wall Street analysts have a consensus price target for the stock at $22, which means that the shares’ value could jump 38.98% from current levels. The projected low price target is $17 while the price target rests at a high of $27. In that case, then, we find that the current price level is +70.56% off the targeted high while a plunge would see the stock lose 7.39% from current levels.
Mylan N.V. (MYL) estimates and forecasts
12 analysts offering their estimates for the company have set an average revenue estimate of $2.99 Billion for the current quarter. 9 have an estimated revenue figure of $3.26 Billion for the next quarter concluding in December 01, 2020. Year-ago sales stood $2.96 Billion and $3.19 Billion respectively for this quarter and the next, and analysts expect sales will grow by 0.9% for the current quarter and 2.2% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -58% over the past 5 years. Earnings growth for 2020 is a modest -95% while over the next 5 years, the company’s earnings are expected to increase by 2.35%.
Mylan N.V. (NASDAQ:MYL)’s Major holders
Insiders own 1.37% of the company shares, while shares held by institutions stand at 87.96% with a share float percentage of 89.19%. Investors are also buoyed by the number of investors in a company, with Mylan N.V. having a total of 741 institutions that hold shares in the company. The top two institutional holders are Wellington Management Company, LLP with over 58.09 Million shares worth more than $934.04 Million. As of June 29, 2020, Wellington Management Company, LLP held 11.24% of shares outstanding.
The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 57.34 Million shares as of June 29, 2020. The firm’s total holdings are worth over $922.08 Million and represent 11.09% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund. As of April 29, 2020, the former fund manager holds about 9.71% shares in the company for having 50185811 shares of worth $841.62 Million while later fund manager owns 14.75 Million shares of worth $237.16 Million as of June 29, 2020, which makes it owner of about 2.85% of company’s outstanding stock.